Por: New York Post Nation March 27, 2023
About one-third of metro area residents consider themselves overweight — and nearly one-quarter say they’d pop a prescriptionto shed extra pounds, a new survey shows. Ten percent of respondents from the city and Long Island are already taking, or know someone using, the drugs Ozempic, Mounjaro, or Wegovy to lose weight, according to the Mount Sinai South Nassau Truth in Medicine Poll. The drugs have with the rich and famous set looking to... + full article
Forbes USA Life April 01, 2023
Outside the Metropolitan Museum of Art in New York CityNewsday via Getty Images Paying for entry into a museum, aquarium, zoo or performing arts center may no longer be necessary for New York residents. , a campaign seeking to codify New Yorkers’ right to free admission to the... + más
Author readings around Boston Sept. 25-Oct. 1 | The Boston Globe
Gov. Hochul to propose law that will let New Yorkers recoup stolen public assistance benefits | New York Daily News
Ars Technica USA Science February 16, 2023
Navigate Filter by topic Settings Front page layout Site theme - Feb 16, 2023 4:57 pm UTC / A woman with diabetes pricks her finger to take a blood sample to measure the glycemia in Paris on March 24, 2020. Share this story A person's odds of getting a new diabetes... + más
Type 1 Diabetes: U.K. To Launch Childhood Screening Program | Forbes
Do Statins Increase the Risk of Diabetes? | The New York Times
Los Angeles Times USA Science December 23, 2022
For more than a month, Shane Anthony, a 57-year-old auto mechanic, hasn’t been able to get his diabetes medication. Ozempic, an injection that keeps blood sugar levels in check for patients with Type 2 diabetes, has been in shortage for about four months, according to the... + más
What To Know About Ozempic: The Diabetes Drug Becomes A Viral Weight Loss Hit (Elon Musk Boasts Using It) Creating A Shortage | Forbes
What to know about Ozempic as demand for the drug leads to shortage | ABC News
ABC News USA Health November 18, 2022
For the first time, the U.S. Food and Drug Administration on Thursday approved a treatment that can delay the onset of .Teplizumab, a monoclonal antibody that will be marketed under the brand name Tzield from pharmaceutical companies ProventionBio and Sanofi, is administered... + más
FDA Oks Provention Bio's Tzield To Delay Onset Of Type 1 Diabetes | RTTNews
FDA approves 1st drug to delay the onset of Type 1 diabetes | NBC News
Forbes USA Tech November 15, 2022
A young girl with diabetes injects herself with insulin. getty Twenty thousand U.K. children will be screened for type one diabetes in a landmark study that could lead to a national scheme. The (EarLy Surveillance for Autoimmune diabetes) program will use blood tests to identify... + más
What to Know About Bariatric Surgery for Type 2 Diabetes | Time
Time USA Health November 11, 2022
After spending nearly two decades trying to , Agnes Czuchlewski landed in the emergency room in 2015, with news that she’d just experienced a heart attack. She also learned that she had metabolic syndrome, a cluster of conditions that includes diabetes but also brings higher... + más
The New York Times USA Health October 25, 2022
Q: Do statins increase the risk of Type 2 diabetes?If you’re among the tens of millions of Americans who could and yet don’t take one, your hesitance may partly stem from worries about its side effects, said Dr. Savitha Subramanian, an endocrinologist at the University of... + más
Women with diabetes almost twice as likely to die prematurely: Study | Newsweek
Why people with diabetes are more likely to suffer dreaded ‘trigger finger’ | New York Post
About iurex | Privacy Policy | Disclaimer |